Coralie Tardivon, Solène Desmée, Marion Kerioui, René Bruno, Benjamin Wu, et al.. Association between tumor size kinetics and survival in urothelial carcinoma patients treated with atezolizumab: implication for patient's follow‐up. Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, In press, Epub ahead of print. ⟨10.1002/cpt.1450⟩. ⟨inserm-02103513⟩
Solène Desmée, France Mentré, Christine Veyrat-Follet, Bernard Sébastien, Jérémie Guedj. Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer. BMC Medical Research Methodology, BioMed Central, 2017, 17 (1), pp.105. ⟨10.1186/s12874-017-0382-9⟩. ⟨inserm-01567365⟩
Solène Desmée, France Mentré, Christine Veyrat-Follet, Bernard Sébastien, Jeremie Guedj. Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients. Biometrics, Wiley, 2016, 73 (1), pp.305-312. ⟨10.1111/biom.12537⟩. ⟨inserm-01340693⟩
Solène Desmée, France Mentré, Christine Veyrat-Follet, Jérémie Guedj. Nonlinear Mixed-Effect Models for Prostate-Specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: a Comparison by Simulation of Two-Stage and Joint Approaches. The AAPS Journal, 2015, pp.1550-7416. ⟨link.springer.com⟩. ⟨10.1208/s12248-015-9745-5⟩. ⟨inserm-01130444⟩
Brigitte Lacour, Stéphanie Goujon, Sandra Guissou, Aurélie Guyot-Goubin, Solène Desmée, et al.. Childhood cancer survival in France, 2000–2008. European Journal of Cancer Prevention, Lippincott, Williams & Wilkins, 2014, 23 (5), pp.449 - 457. ⟨10.1097/CEJ.0000000000000006⟩. ⟨hal-01801206⟩
Theses1 document
Solène Desmée. Modélisation conjointe de données longitudinales non-linéaires et de données de survie : Application au cancer de la prostate métastatique. Statistiques [stat]. Université Paris Diderot (Paris 7) Sorbonne Paris Cité, 2016. Français. ⟨tel-01484089⟩
